Douglas McNair

2.9k total citations · 1 hit paper
37 papers, 1.8k citations indexed

About

Douglas McNair is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Epidemiology. According to data from OpenAlex, Douglas McNair has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 6 papers in Economics and Econometrics and 5 papers in Epidemiology. Recurrent topics in Douglas McNair's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Chronic Disease Management Strategies (3 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). Douglas McNair is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Chronic Disease Management Strategies (3 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). Douglas McNair collaborates with scholars based in United States, Canada and Argentina. Douglas McNair's co-authors include Andrew A. Kramer, Jack E. Zimmerman, Daniel Krewski, Donald R. Mattison, Sharon Eve Sonenblum, Stephen Sprigle, Yannick Fortin, James A. G. Crispo, Lise M. Bjerre and Patricia W. Finn and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Douglas McNair

33 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acute Physiology and Chronic Health Evaluation (APACHE) IV: Hospital mortality assessment for today’s critically ill patients*

2006 1.2k citations Jack E. Zimmerman, Andrew A. Kramer et al. Critical Care Medicine profile →

Peers

Douglas McNair

EPIDE

SURGE

CCM

CCICM

Ricardo Abizanda Campos Spain

Brian W. Pickering United States

Barbara Jordan Austria

David Edbrooke United Kingdom

Prabath W.B. Nanayakkara Netherlands

D. Villers France

Omar Badawi United States

Michael W. Sjoding United States

G. Iapichino Italy

Tezcan Ozrazgat‐Baslanti United States

Ricardo Abizanda Campos Spain

Douglas McNair

881 ×1.1

EPIDE

383 ×0.9

423 ×1.1

SURGE

402 ×1.3

CCM

373 ×1.4

CCICM

Citations per year, relative to Douglas McNair Douglas McNair (= 1×) peers Ricardo Abizanda Campos

Countries citing papers authored by Douglas McNair

Since Specialization

Citations

This map shows the geographic impact of Douglas McNair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas McNair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas McNair more than expected).

Fields of papers citing papers by Douglas McNair

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas McNair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas McNair. The network helps show where Douglas McNair may publish in the future.

Co-authorship network of co-authors of Douglas McNair

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas McNair. A scholar is included among the top collaborators of Douglas McNair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas McNair. Douglas McNair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mandema, Jaap W., Hugh Montgomery, Louis Dron, et al.. (2023). Totality of evidence of the effectiveness of repurposed therapies for COVID‐19: Can we use real‐world studies alongside randomized controlled trials?. Clinical and Translational Science. 16(10). 1842–1855. 1 indexed citations

Grillo, Joseph A., Douglas McNair, & Ping Zhao. (2023). Coming full circle: The potential utility of real‐world evidence to discern predictions from a physiologically based pharmacokinetic model. Biopharmaceutics & Drug Disposition. 44(4). 344–347. 2 indexed citations

Crispo, James A. G., Yannick Fortin, Douglas McNair, et al.. (2022). Systemic quinolones and risk of retinal detachment III: a nested case–control study using a US electronic health records database. European Journal of Clinical Pharmacology. 78(6). 1019–1028. 7 indexed citations

Brown, Joshua D., Tamra Goodrow, Dan Hartman, et al.. (2022). Application of exposure bracketing to streamline the development of contraceptive products. SHILAP Revista de lepidopterología. 4. 100072–100072.

Crispo, James A. G., Yannick Fortin, Douglas McNair, et al.. (2021). Systemic quinolones and risk of acute liver failure III: A nested case–control study using a US electronic health records database. Journal of Gastroenterology and Hepatology. 36(8). 2307–2314. 4 indexed citations

Wen, Shi Wu, Daniel Krewski, Daniel J. Corsi, et al.. (2021). Association of treatments for acute appendicitis with pregnancy outcomes in the United States from 2000 to 2016: Results from a multi-level analysis. PLoS ONE. 16(12). e0260991–e0260991. 8 indexed citations

Birkett, Nicholas, Yannick Fortin, Franco Momoli, et al.. (2020). Risk of Adverse Cardiovascular Events Following a Myocardial Infarction in Patients Receiving Combined Clopidogrel and Proton Pump Inhibitor Treatment: A Nested Case–Control Study. Drugs - Real World Outcomes. 7(3). 191–203. 7 indexed citations

Sprigle, Stephen, Douglas McNair, & Sharon Eve Sonenblum. (2020). Pressure Ulcer Risk Factors in Persons with Mobility-Related Disabilities. Advances in Skin & Wound Care. 33(3). 146–154. 49 indexed citations

Crispo, James A. G., Nicholas Birkett, Douglas McNair, et al.. (2018). Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000–2016. European Journal of Clinical Pharmacology. 75(2). 227–235. 13 indexed citations

10.

Fortin, Yannick, et al.. (2017). External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality. PLoS ONE. 12(3). e0174379–e0174379. 24 indexed citations

11.

McNair, Douglas & Roy L. Simpson. (2016). Bayesian Cost-effectiveness Analysis of Falls Risk Assessment Tools. Nursing Administration Quarterly. 40(4). 364–369. 3 indexed citations

12.

Crispo, James A. G., Allison W. Willis, Dylan Thibault, et al.. (2016). Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease. PLoS ONE. 11(3). e0150621–e0150621. 78 indexed citations

13.

McNair, Douglas. (2015). Enhancing Nursing Staffing Forecasting With Safety Stock Over Lead Time Modeling. Nursing Administration Quarterly. 39(4). 291–296. 4 indexed citations

14.

McNair, Douglas, et al.. (2015). Off-label use of cancer therapies in women diagnosed with breast cancer in the United States. SpringerPlus. 4(1). 209–209. 13 indexed citations

15.

Dorsselaer, Alain Van, Christine Carapito, François Delalande, et al.. (2011). Detection of Prion Protein in Urine-Derived Injectable Fertility Products by a Targeted Proteomic Approach. PLoS ONE. 6(3). e17815–e17815. 29 indexed citations

16.

McNair, Douglas, et al.. (2010). A novel dry powder inhaler: Effect of device design on dispersion performance. International Journal of Pharmaceutics. 401(1-2). 1–6. 21 indexed citations

17.

Zimmerman, Jack E., et al.. (2006). Acute Physiology and Chronic Health Evaluation (APACHE) IV: Hospital mortality assessment for today’s critically ill patients*. Critical Care Medicine. 34(5). 1297–1310. 1210 indexed citations breakdown →

18.

Zimmerman, Jack E., et al.. (2006). Intensive care unit length of stay: Benchmarking based on Acute Physiology and Chronic Health Evaluation (APACHE) IV*. Critical Care Medicine. 34(10). 2517–2529. 180 indexed citations

19.

Zimmerman, Jack E., et al.. (2005). ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION (APACHE)IV ICU LENGTH OF STAY BENCHMARKS FOR TODAY'S CRITICALLY ILL PATIENTS. CHEST Journal. 128(4). 297S–297S. 4 indexed citations

20.

Lederman, David, R. T. V. Kung, & Douglas McNair. (2002). Therapeutic Potential of Implantable Replacement Hearts. American Journal of Cardiovascular Drugs. 2(5). 297–301. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact